A Delta-Aminolevulinic Acid Dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the Normative Aging Study (Q24813832)
Jump to navigation
Jump to search
journal article published in 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Delta-Aminolevulinic Acid Dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the Normative Aging Study |
journal article published in 2003 |
Statements
2 references
A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study (English)
1 reference
A Delta-Aminolevulinic Acid Dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the Normative Aging Study (English)
1 reference
1 reference
21 June 2020
Health effects
1 reference
21 June 2020
Joel Schwartz
Schwartz J
2 references
21 June 2020
Karl Kelsey
1 reference
Ming-Tsang Wu
1 reference
David Sparrow
1 reference
Scott Weiss
1 reference
Howard Hu
1 reference
1 March 2003
1 reference
2 references
21 June 2020
111
1 reference
335-341
1 reference
Harvard School of Public Health
1 reference
2 February 2024
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference